<DOC>
	<DOCNO>NCT00629252</DOCNO>
	<brief_summary>This study aim investigate whether atypical antipsychotic mixed 5-HT2/D2 antagonist sertindole modulate improve subcortical cortical information processing schizophrenic patient insufficiently respond previous antipsychotic medication . This goal shall accomplish investigate effect sertindole prepulse inhibition acoustic startle ( PPI ) P50 suppression auditory evoke potential schizophrenic patient . These effect shall compare effect risperidone shall also compare untreated healthy control .</brief_summary>
	<brief_title>The Effect Sertindole Sensory Gating Cognition Schizophrenic Patients</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Sertindole</mesh_term>
	<criteria>Schizophrenia accord DSM IV Selected treat respect SPC ( 20 mg Serdolect max . population risk exclude ) DSM IV Axis I disorder schizophrenia : Substancedependence ( except nicotinedependence substanceabuse ) , recent ( 2 month ) DSM IV diagnosis accord DIAX major affective , anxiety disorder , eatingdisorder . DSM IV Axis II disorder : Lifetime DSM IV diagnosis personality disorder . ECG : QTcinterval &gt; 450 msec . Systolic blood pressure &lt; 100 mmHg Bradycardia ( Hf &lt; 50/Min ) und Arrhythmias Hypokalemia Hypomagnesemia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>PPI</keyword>
	<keyword>P50</keyword>
	<keyword>CANTAB</keyword>
	<keyword>sensory gating</keyword>
	<keyword>Schizophrenic patient accord DSM-IV</keyword>
</DOC>